Engrail Therapeutics Raises $157M in Series B Funding Round
TLDR: Key Points: Engrail Therapeutics has secured USD 157 million in Series B funding led by F-Prime Capital, Forbion, and Norwest Venture Partners. The funding will support the advancement of the company’s